Cargando…
Treatment strategies of COVID-19: A rheumatology perspective
The clinical progression of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) to critical illness is associated with a systemic and uncontrolled inflammatory response of the innate and adaptive immunity with the release of a plethora of proinflammatory cytokines termed “cytokine storm...
Autores principales: | Drosos, Alexandros A., Pelechas, Eleftherios, Voulgari, Paraskevi V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095447/ https://www.ncbi.nlm.nih.gov/pubmed/35610165 http://dx.doi.org/10.1016/j.ejim.2022.05.014 |
Ejemplares similares
-
Long COVID from rheumatology perspective: a simple mimicker or promoter of autoimmunity?
por: Drosos, Alexandros A., et al.
Publicado: (2022) -
Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019) -
COVID-19 in patients with gout on colchicine
por: Pelechas, Eleftherios, et al.
Publicado: (2021) -
Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients
por: Pelechas, Eleftherios, et al.
Publicado: (2022) -
Golimumab for Rheumatoid Arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019)